A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. (Q53043418)
Jump to navigation
Jump to search
scientific article published on 22 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. |
scientific article published on 22 August 2016 |
Statements
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. (English)
1 reference
1 reference
Mark R Litzow
1 reference
Keith W Pratz
1 reference
Michelle A Rudek
1 reference
Ivana Gojo
1 reference
Michael A McDevitt
1 reference
Jiuping Ji
1 reference
Larry M Karnitz
1 reference
James G Herman
1 reference
Robert J Kinders
1 reference
B Douglas Smith
1 reference
Steven D Gore
1 reference
Hetty E Carraway
1 reference
Margaret M Showel
1 reference
Douglas E Gladstone
1 reference
Mark J Levis
1 reference
Hua-Ling Tsai
1 reference
Gary Rosner
1 reference
Alice Chen
1 reference
Judith E Karp
1 reference
22 August 2016
1 reference
23
1 reference
4
1 reference
899-907
1 reference
1 reference
1 reference